Tawfeeg A. O. Najjar
Tawfeeg A. O. Najjar publishes mostly in Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Pharmacology, on topics such as Chemotherapy-induced organ toxicity mitigation, Antibiotics Pharmacokinetics and Efficacy and Chemotherapy-induced cardiotoxicity and mitigation.
- World rank
- #4,651,463 of 7,710,434 ranked researchers
- Rank in Saudi Arabia
- #18,625 of 25,688
- Works
- 29
- Citations
- 858
- Citations per work
- 29.6
What does Tawfeeg A. O. Najjar research?
Tawfeeg A. O. Najjar's work is mostly in Medicine (46%), Chemistry (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1447.2%
- Health Sciences1346.0%
- Medicine1346.0%
- Physical Sciences26.8%
- Chemistry26.8%
- 1Pathology and Forensic Medicine11% of their works
- 2Cardiology and Cardiovascular Medicine11% of their works
- 3Pharmacology11% of their works
- 4Oncology7% of their works
- 5Analytical Chemistry7% of their works
- 6Pediatrics, Perinatology and Child Health7% of their works
Research topics
- Chemotherapy-induced organ toxicity mitigation
- Antibiotics Pharmacokinetics and Efficacy
- Chemotherapy-induced cardiotoxicity and mitigation
- Analytical Methods in Pharmaceuticals
- Pharmacogenetics and Drug Metabolism
- Acute Lymphoblastic Leukemia research
- Antimicrobial Resistance in Staphylococcus
- Drug Transport and Resistance Mechanisms
Which keywords describe Tawfeeg A. O. Najjar's research?
The keywords of their largest research topics: Chemotherapy, Oxidative Stress, Antimicrobial Resistance, Antibiotic Pharmacokinetics, Cisplatin, Critically Ill Patients, Nephrotoxicity and Anthracyclines.
- Multidrug Resistance
- ATP-dependent Transporters
- Cytochrome P450
- Acute Lymphoblastic Leukemia
- Green Analytical Chemistry
- Anthracyclines
- Critically Ill Patients
- Antibiotic Pharmacokinetics
- Oxidative Stress
- Chemotherapy
- Antimicrobial Resistance
- Cisplatin
- Nephrotoxicity
- Doxorubicin
- Pharmaceutical Analysis
- Childhood Cancer
- Pharmacogenetics
- MRSA
- Staphylococcus aureus
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Chemotherapy132 topics
- Oxidative Stress132 topics
- Antimicrobial Resistance102 topics
- Antibiotic Pharmacokinetics71 topic
- Cisplatin71 topic
- Critically Ill Patients71 topic
- Nephrotoxicity71 topic
- Anthracyclines61 topic
- Doxorubicin61 topic
- Green Analytical Chemistry51 topic
- Pharmaceutical Analysis51 topic
- Acute Lymphoblastic Leukemia41 topic
- Childhood Cancer41 topic
- Cytochrome P45041 topic
- Pharmacogenetics41 topic
- ATP-dependent Transporters31 topic
- MRSA31 topic
- Multidrug Resistance31 topic
- Staphylococcus aureus31 topic
Where does Tawfeeg A. O. Najjar work?
Tawfeeg A. O. Najjar's main affiliation in the publication record is King Saud University, Saudi Arabia.
How many publications and citations does Tawfeeg A. O. Najjar have?
OpenAlex counts 29 works and 858 citations for Tawfeeg A. O. Najjar, an h-index of 14, ranking #4,651,463 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tawfeeg A. O. Najjar. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.